0
0
4/25/23 at 4:25pm
Organization
CNBC
Author
Spencer Kimball
37 words
0
Comments
Bavarian Nordic plans to sharply scale up production of its Jynneos vaccine to prepare for a smallpox emergency, CEO Paul Chaplin said.
You are the first to view
https://www.cnbc.com/2023/04/25/mpox-shows-smallpox-risk-vaccine-maker-bavarian-nordic-says.html
Create an account
or login to join the discussion